2021

Client News

X-Chem Announces OpenDEX DNA-Encoded Library Screening

May 11, 2021
Client News

Nexelis Wins ViE Award for Best Central/Specialty Laboratory

May 11, 2021
Client News

Noxopharm’s Veyonda to Begin First-Line Sarcoma Treatment Testing

May 11, 2021
Client News

Elligo Health Research and Harris Computer Announce Partnership

May 6, 2021
Client News

Global Genes Launches RARE Health Equity Council to Help Build a More Inclusive Healthcare System and Improve Access and Experiences for Underserved Patients with Rare Diseases

May 5, 2021
Client News

Clinical Ink Hires CCO Chris Crucitti, COO Brian Donahue, VP Bill Barrasso

May 4, 2021
Client News

AMRI Adds to Accelerated R&D and Manufacturing Solutions for Orphan Products to Treat Rare Diseases

April 30, 2021
Client News

Global Genes and Orphan Disease Center of the University of Pennsylvania to Convene Patient Group Leaders, Researchers, Clinicians and Industry for 6th Annual RARE Drug Development Symposium

April 29, 2021
Client News

Clinical Data Shows Noxopharm’s Veyonda® May Prevent Cytokine Storm

April 27, 2021
Client News

SANUWAVE® Rebrands to Reflect Evolved Wound Care Solutions

April 20, 2021
Client News

Clinical Ink Deploys eCOA Solutions for Industry’s Most-Complex Assessments

April 20, 2021
Client News

Noxopharm Files Septic Shock Treatment Patent for Veyonda®

April 14, 2021

Gain a Strategic Advantage

Connect With Our Life Science Experts